Tech Company Financing Transactions
Stemgent Funding Round
Stemgent closed a $14 million Series A funding round on 3/9/2009. Backers included HealthCare Ventures and Morgenthaler Ventures.
Transaction Overview
Company Name
Announced On
3/9/2009
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 Hartwell Pl.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Stemgent advances stem cell science by providing proprietary reagents and tools developed and proven for reproducibility by some of the world's leading stem cell scientists.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rama Modali
Browse more venture capital transactions:
Prev: 3/9/2009: Haute Secure venture capital transaction
Next: 3/9/2009: Surface Logix venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs